Denmark· DK-28107452725
Urisotam
A tamsulosin und solifenacin product containing solifenacinsuccinat, tamsulosinhydrochlorid, registered in Denmark by Orifarm A/S. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Tamsulosin und solifenacin is registered in 9 of 19 countries.
Countries holding a registration under ATC G04CA53 (tamsulosin und solifenacin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 6 of them publish a price we can compare per daily dose
Tamsulosin und solifenacin · ATC G04CA53
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Solifenacinsuccinat, TAMSULOSINHYDROCHLORID
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- G04CA53
- ATC class
- Tamsulosin und Solifenacin
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28107452725
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under G04CA53
Tamsulosin und solifenacin, as other registers publish it.
- PolandBeplasot+pharma arzneimittel GmbH
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
- CzechiaBEPLASOT+pharma arzneimittel gmbh, Graz
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e80c900d-d745-492b-906b-0dbe738086cb GET /v1/drugs/e80c900d-d745-492b-906b-0dbe738086cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "tabletter med modificeret udløsning",
"source": "dkma",
"strength": "6+0,4 mg",
"auth_role": "DKMA",
"dk_drugid": "28107452725",
"substance": "Solifenacinsuccinat, TAMSULOSINHYDROCHLORID",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "45940"
}See everything about tamsulosin und solifenacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.